Cytokine/chemokine profile in J774 macrophage cells persistently infected with da strain of theiler's murine encephalomyelitis virus (TMEV)

Journal of NeuroVirology

Volumn 16, Issue 3, 2010, Pages 219-229

  Himeda, Toshiki ^a   Okuwa, Takako ^a   Muraki, Yasushi ^a   Ohara, Yoshiro ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytokine; Demyelination; Macrophage; Persistent infection; TMEV

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOATTRACTANT; CHEMOKINE; COLONY STIMULATING FACTOR 1; CXCL11 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 23; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; NONSTRUCTURAL PROTEIN; RANTES; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; MACROPHAGE; MOUSE; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PICORNAVIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VIROGENESIS; VIRUS STRAIN;

ACUTE DISEASE; ANIMALS; ANTIBODIES; CARDIOVIRUS INFECTIONS; CELL LINE; CHEMOKINES; CYTOKINES; DEMYELINATING DISEASES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERON-GAMMA; INTERLEUKIN-10; MACROPHAGES; MICE; MICE, INBRED BALB C; RNA, MESSENGER; THEILOVIRUS;

MUS; PICORNAVIRIDAE; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 77953176566     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550284.2010.484040     Document Type: Article

References (46)

1. Bagaeva LV, Rao P, Powers JM, Segal M (2006). CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J Immunol 176: 7676-7685.
2. Blanco Y, Saiz A, Carreras E, Graus F (2005). Autologous haematopoietic-stem-cell transplantation for multiple sclerosis. Lancet Neurol 4: 54-63.
3. Boldogh I, Albrecht T, Porter DD (1996). Persistent viral infections. In Medical microbiology, 4th ed. Baron S (ed). Galveston, TX: The University of Texas Medical Branch at Galveston.
4. Chang JR, Zaczynska E, Katsetos CD, Platsoucas CD, Oleszak EL (2000). Differential expression of TGF-b, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strain of mice. Virology 278: 346-360.
5. Clatch RJ, Miller SD, Metzner R, Dal Canto MC, Lipton HL (1990). Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 176: 244-254.
6. Delhaye S, van Pesch V, Michiels T (2004). The leader protein of Theiler's virus interferes with nucleocyto-plasmic trafficking of cellular proteins. J Virol 78: 4357-4362.
7. Demetri GD, Griffin JD (1991). Granulocyte colony-stimulating factor and its reseptor. Blood 78: 2791-2808.
8. de Waal-Malefy R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE (1991). IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity on mono-cytes via down-regulation of class II MHC expression. J Exp Med 174: 915-924.
9. Drescher KM, Pease LR, Rodriguez M (1997). Antiviral immune responses modulate the nature of central nervous system (CNS) disease in a murine model of multiple sclerosis. Immunol Rev 159: 177-193.
10. Fan J, Son K, Arslan SY, Liang Z, Lipton HL (2009). The Theiler's murine encephalomyelitis virus leader protein is the only nonstructural protein tested that induces apoptosis when transfected into mammalian cells. J Virol 83: 6546-6553.
11. Fiette L, Aubert C, Muller U, Huang S, Aguet M, Brahic M, Bureau JF (1995). Theiler's virus infection of 129Sv mice that lack the interferon a/b or interferon g receptors. J Exp Med 181: 2069-2076.
12. Fiorentino DF, Zlotnic A, Viera P, Mosmann TR, Howard M, Moore KW, O'Garra A (1991). IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146: 3444-3451.
13. Hato SV, Ricour C, Schulte BM, Lanke KHW, de Bruijnu M, Zoll J, Melchers WJG, Michiels T, van Kuppeveld FJM (2007). The mengovirus leader protein blocks inter-feron-a/b gene transcription and inhibits activation of interferon regulatory factor 3. Cell Microbiol 9: 2921-2930.
14. Himeda T, Ohara Y, Asakura K, Kontani Y, Murakami M, Suzuki H, Sawada M (2005). A lentiviral expression system demonstrates that L* protein of Theiler's murine encephalomyelitis virus (TMEV) is essential for virus growth in a murine macrophage-like cell line. Virus Res 108: 23-28. (Pubitemid 40173963)
15. Ichinose-Asakura K, Taniura N, Himeda T, Nojiri M, Okuwa T, Ohara Y (2010). Leader (L) of Theiler's murine encephalomyelitis virus (TMEV) is required for virus growth in a murine macrophage-like cell line. Virus Res 147: 224-230.
16. Kong WP, Ghadge GD, Roos RP (1994). Involvement of cardiovirus leader in host cell-restricted virus expression. Proc Natl Acad Sci USA 91: 1796-1800.
17. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E (2005). Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 129: 200-211.
18. Law KM, Brown TDK (1990). The complete nucleotide sequence of the GDVII strain of Theiler's murine encephalomyelitis virus (TMEV). Nucleic Acid Res 18: 6707-6708.
19. Lipton HL, Kumar ASM, Trottier M (2005). Theiler's virus persistence in the central nervous system of mice is associated with continuous viral replication and a difference in outcome of infection of infiltrating macro-phages versus oligodendrocytes. Virus Res 111: 214-223.
20. Lipton HL, Twaddle G, Jelachich ML (1995). The predominant virus antigen burden is present in macro-phages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J Virol 69: 2525-2533.
21. Michiels T, Jarousse N, Brahic M (1995). Analysis of the leader and capsid coding regions of persistent and neurovirulent strains of Theiler's virus. Virology 214: 550-558.
22. Nitayaphan S, Toth MM, Roos RP (1985). Neutralizing monoclonal antibodies to Theiler's murine encephalo-myelitis viruses. J Virol 53: 651-657.
23. Monteyne P, Bureau J-F, Brahic M (1997). The infection of mouse by Theiler's virus: from genetics to immunology. Immunol Rev 159: 163-176. (Pubitemid 27499867)
24. Oba M, Yano S, Shuto T, Suico MA, Eguma A, Kai H (2008). IFN-g down-regulates Hsp27 and enhances hyperthermia-induced tumor cell death in vitro and tumor suppression in vivo. Int J Oncol 32: 1317-1324.
25. Obuchi M, Ohara Y (1998). Theiler's murine encephalo-myelitis virus and mechanisms of its persistence. Neu-ropathology 18: 13-18.
26. Obuchi M, Yamamoto J, Uddin N, Odagiri T, Iizuka H, Ohara Y (1999). Theiler's murine encephalomyelitis virus (TMEV) subgroup strain-specific infection in neural and non-neural cell lines. Microbiol Immunol 43: 885-892.
27. Ohara Y, Stein S, Fu J, Stillman L, Klaman L, Roos RP (1988). Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology 164: 245-255.
28. Oleszak EL, Chang JR, Friedman H, Katsetos CD, Platsoucas CD (2004). Theiler's virus infection: a model for multiple sclerosis. Clin Microbiol Rev 17: 174-207.
29. Openshaw H, Stuve O, Antel JP, Nash R, Lund BT, Weiner LP, Kashyap A, McSweeney P, Forman S (2000). Multiple sclerosis flares associated with recombinant gran-ulocyte colony-stimulating factor. Neurology 54: 2147-2150.
30. Palma JP, Kim BS (2004). The scope and activation mechanisms of chemokine gene expression in primary astrocytes following infection with Theiler's virus. J Neuroimmunol 149: 121-129.
31. Ralph P, Prichard J, Cohn M (1975). Reticulum cell sarcoma: an effector cell in antibody-dependent cell-mediated immunity. J Immunol 114: 898-905.
32. Ransohoff RM, Wei T, Pavelko KD, Lee J-C, Murray PD, Rodriguez M (2002). Chemokine expression in the central nervous system of mice with a viral disease resembling multiple sclerosis: Role of CD4+ and CD8+ T cell and viral persistence. J Virol 76: 2217-2224.
33. Rodriguez M, Zoecklein LJ, Howe CL, Pavelko KD, Gamez JD, Nakane S, Papke LM (2003). Gamma interferon is critical for neuronal viral clearance and protection in a susceptible mouse strain following early intracranial Theiler's murine encephalomyelitis virus infection. J Virol 77: 12252-12265.
34. Roos RP (2002). Pathogenesis of Theiler's murine enceph-alomyelitis virus-induced disease. In Molecular biology of picornaviruses. Semler BL, Wimmer E (eds). Washington, DC: ASM Press, pp 427-436.
35. Roos RP, Richards OC, Green J, Ehrenfeld E(1982). Characterization of a cell culture persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. J Virol 43: 1118-1122.
36. Snir O, Lavie G, Achiron A, Bank I, Ben-Aharon T, Sredni B, Cohen IR, Mandel M (2006). G-CSF enhances the adhesion of encephalitogenic T cells to extracellular matrix components: A possible mechanism for exacerbation of multiple sclerosis. J Neuroimmunol 172: 145-155.
37. Son K-N, Becker RP, Kallio P, Lipton HL (2008). Theiler's Virus-Induced Intrinsic Apoptosis in M1-D macro-phages is Bax mediated and restricts virus infectivity: a mechanism for persistence of a cytolytic virus. J Virol 82: 4502-4510.
38. Son K-N, Pugazhenthi S, Lipton HL (2009). Activation of tumor suppressor protein p53 is required for Theiler's murine encephalomyelitis virus-induced apoptosis in M1-D macrophages. J Virol 83: 10770-10777.
39. Steurbaut S, Merckx E, Rombaut B, Vrijsen R (2008). Modulation of viral replication in macrophages persistently infected with the DA strain of Theiler's murine encephalomyelitis virus. Virol J 5: 89-98.
40. SteurbautS,RombautB,VrijsenR(2006). Persistent infection of RAW264.7 macrophages with the DA strain of Theiler's murine encephalomyelitis virus: An in vitro model to study viral persistence. J NeuroVirol 12: 108-115.
41. Steurbaut S, Rombaut B, Vrijsen R (2006). Theiler's virus strain-dependent induction of innate immune responses in RAW264.7 macrophages and its influence on viral clearance versus viral persistence. J NeuroVirol 13: 47-55.
42. Taga KG, Tosato G (1992). IL-10 inhibits T cell proliferation and IL-2 production. J Immunol 148: 1143-1148.
43. Takata H, Obuchi M, Yamamoto J, Odagiri T, Roos RP, Iizuka H, Ohara Y (1998). L* protein of the DA strain of Theiler's murine encephalomyelitis virus is important for virus growth in a murine macrophage-like cell line. J Virol 72: 4950-4955.
44. van Pesch V, van Eyll O, Michiels T (2001). The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J Virol 75: 7811-7817.
45. Wang L, Goillot E, Tepper RJ (1994). IL-10 inhibits allor-eactive cytotoxic T lymphocyte generation in vivo. Cell Immunol 159: 152-169.
46. Yonekura N, Yokota S, Yonekura K, Dehari H, Arata S, Kohama G, Fujii N (2003). Interferon-g downregulates Hsp27 expression and suppression the negative regulation of cell death in oral squamous cell carcinoma line. Cell Death Differ 10: 313-322.